CEACAM1 and neoplasm: F. nucleatum also bound and activated the cell inhibitory receptor CEACAM1 on CEACAM1 + tumor-infiltrating lymphocytes and CEACAM1 + tumor cells, indicating its potential significance in modulating antitumor immunity and aiding the tumor in evading immune cell attack through an additive mechanism [25].